Clofazimine-d7

• CAT Number: R049357
• Molecular Formula: C27H15D7Cl2N4
• Molecular Weight: 480.44
• Purity: ≥95%
• Synonyms: N,5-bis(4-chlorophenyl)-3-(1,1,1,2,3,3,3-heptadeuteriopropan-2-ylimino)phenazin-2-amine
• InChI: InChI=1S/C27H22Cl2N4/c1-17(2)30-24-16-27-25(15-23(24)31-20-11-7-18(28)8-12-20)32-22-5-3-4-6-26(22)33(27)21-13-9-19(29)10-14-21/h3-17,31H,1-2H3/i1D3,2D3,17D
• InChIKey: WDQPAMHFFCXSNU-WFBMWZOZSA-N
• SMILES: [2H]C([2H])([2H])C([2H])(C([2H])([2H])[2H])N=C1C=C2C(=NC3=CC=CC=C3N2C4=CC=C(C=C4)Cl)C=C1NC5=CC=C(C=C5)Cl

Clofazimine-d7（Cat No.:R049357）is a deuterated form of clofazimine, a medication primarily used to treat leprosy and multidrug-resistant tuberculosis. The “d7” indicates the replacement of seven hydrogen atoms with deuterium, an isotope of hydrogen, making it useful for isotopic labeling in research. This modification allows researchers to trace the drug’s behavior in biological systems and study its pharmacokinetics, metabolism, and interactions without interference from natural isotopic variations. Clofazimine-d7 helps in understanding the drug’s pharmacological properties, efficacy, and potential side effects, enhancing research on tuberculosis and other mycobacterial diseases.